Valneva SE (VALN) EBT Margin (2021 - 2026)
Valneva SE (VALN) posted EBT Margin of 101.12% for Q1 2026, up 23.79% sequentially from 132.67% in Q4 2025, and down 8536.0% YoY from 1.2% in Q1 2025.
Powered by 
Analysis
Valneva SE (VALN) EBT Margin (2021 - 2026) Analysis & Trends
Valneva SE has reported EBT Margin for 6 years, with the latest figure at 101.12% in Q1 2026.
- Quarterly EBT Margin fell 8536.0% year-over-year to 101.12% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 99.38% (down 5583.0% YoY) and the FY2025 annual result came in at 72.27%, down 6524.0% from the prior year.
- EBT Margin grew to 101.12% in Q1 2026 per VALN's latest filing, from 132.67% in the prior quarter.
- Over five years, EBT Margin peaked at 179.89% in Q1 2024 and troughed at 201.3% in Q2 2022.
- A 5-year average of 60.28% and a median of 63.68% in 2024 frame the typical range for EBT Margin.
- The sharpest annual moves came in 2022 and 2025: EBT Margin surged 75573 bps in 2022, then sank 19564 bps in 2025.
- Over 5 years, EBT Margin stood at 43.0% in 2022, then plunged by 57 bps to 67.44% in 2023, then gained by 6 bps to 63.68% in 2024, then slumped by 108 bps to 132.67% in 2025, then gained by 24 bps to 101.12% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 101.12%, 132.67%, and 199.07% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | 35.78% |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | -528.97% |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 18.33% |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | 13.77% |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | 12.09% |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -2.67% |
| 10 | Valneva SE | 580.64 Mn | 439.38 Mn | 1.86 Mn | -90.93% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -90.93% |
| Mar 31, 2026 | -101.12% |
| Dec 31, 2025 | -107.11% |
| Sep 30, 2025 | -147.82% |
| Jun 30, 2025 | -24.43% |
| Mar 31, 2025 | -15.76% |
| Dec 31, 2024 | -61.10% |
| Sep 30, 2024 | -28.27% |
| Jun 30, 2024 | -65.95% |
| Mar 31, 2024 | 179.89% |
| Dec 31, 2023 | -67.44% |
| Sep 30, 2023 | -82.87% |
| Jun 30, 2023 | -51.14% |
| Mar 31, 2023 | -54.46% |
| Dec 31, 2022 | -43.00% |
| Sep 30, 2022 | 46.15% |
| Jun 30, 2022 | -201.30% |
| Mar 31, 2022 | -116.90% |
| Dec 31, 2021 | 62.65% |
| Sep 30, 2021 | -709.58% |